Literature DB >> 16924449

[Blindness in Germany--today and in 2030].

C Knauer1, N Pfeiffer.   

Abstract

Due to demographic developments in Germany, it is inevitable that the number of age-related diseases will grow. The aim of this survey is to forecast the extent of this development in ophthalmology. How many people will be blind or visually impaired in 25 years from now? According to the German Federation of Blind and Visually Impaired People, the number of blind people in Germany is about 145,000 and the number of the partially sighted people can be estimated at approximately 500,000. These figures are based on the legal definitions of blindness and visual impairment, which are stricter in Germany than in other countries. Due to the ageing population, there will be one third more blind people and about 60% more new cases of blindness in 25 years time. In particular, the incidence rate of blindness due to age-related macular degeneration will rise sharply, but the number of blind people and new cases of blindness are only the top of the "iceberg". The number of people suffering from age related eye diseases in future will be even larger. This large number of future patients already should be part of health economic considerations.

Entities:  

Mesh:

Year:  2006        PMID: 16924449     DOI: 10.1007/s00347-006-1411-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  16 in total

Review 1.  [Age-related macular degeneration. 1. Epidemiology, pathogenesis and differential diagnosis].

Authors:  D Pauleikhoff; F G Holz
Journal:  Ophthalmologe       Date:  1996-06       Impact factor: 1.059

Review 2.  Epidemiology of blindness and eye disease.

Authors:  H G Krumpaszky; V Klauss
Journal:  Ophthalmologica       Date:  1996       Impact factor: 3.250

3.  The dimensions of the problem of eye disease among the elderly.

Authors:  L D Pizzarello
Journal:  Ophthalmology       Date:  1987-09       Impact factor: 12.079

4.  Available data on blindness (update 1994)

Authors:  B Thylefors; A D Négrel; R Pararajasegaram; K Y Dadzie
Journal:  Ophthalmic Epidemiol       Date:  1995-03       Impact factor: 1.648

5.  [Causes of blindness in Hessia in 1996].

Authors:  M Gräf; E Halbach; H Kaufmann
Journal:  Klin Monbl Augenheilkd       Date:  1999-07       Impact factor: 0.700

Review 6.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

7.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

8.  Blindness incidence in Germany. A population-based study from Württemberg-Hohenzollern.

Authors:  H G Krumpaszky; R Lüdtke; A Mickler; V Klauss; H K Selbmann
Journal:  Ophthalmologica       Date:  1999       Impact factor: 3.250

Review 9.  Senile macular degeneration: review of epidemiologic features.

Authors:  F L Ferris
Journal:  Am J Epidemiol       Date:  1983-08       Impact factor: 4.897

10.  Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.

Authors:  Antoine Lafuma; Antoine Brézin; Stefania Lopatriello; Klaus Hieke; Julia Hutchinson; Viviane Mimaud; Gilles Berdeaux
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

View more
  27 in total

1.  [Healthcare "Apps" for Smartphones : Relief or toy for patients and the visual impaired?].

Authors:  C H Meyer; B V Stanzel; S Moqaddem; D Brohlburg
Journal:  Ophthalmologe       Date:  2012-01       Impact factor: 1.059

2.  [Spectrum of ophthalmologic and social rehabilitation at the Tübinger Low-Vision Clinic : a retrospective analysis for 1999-2005].

Authors:  N X Nguyen; M Weismann; S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

3.  [Fundamentals for the medical evaluation of handicapped people in legislation].

Authors:  K Rohrschneider; S Bültmann; I Mackensen
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

4.  [Quality of life by limited vision in old age: the example of age-related macula degeneration].

Authors:  H-W Wahl; V Heyl; N Langer
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

5.  [Ophthalmologic publications from Germany].

Authors:  C Wolfram
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

Review 6.  [Cost of illness of age-related macular degeneration. Systematic review on the development of a costs diary].

Authors:  J Gibbert; D Müller; S Fauser; S Stock
Journal:  Ophthalmologe       Date:  2013-06       Impact factor: 1.059

7.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

8.  [Outcomes and health services research in ophthalmology].

Authors:  C Wolfram; N Pfeiffer
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

9.  [Causes of blindness in students at the school for blind children in Ilvesheim. Changes between 1885 and 2008].

Authors:  K Rohrschneider; I Mackensen
Journal:  Ophthalmologe       Date:  2013-04       Impact factor: 1.059

10.  An epidemiological approach for the estimation of disease onset in Central Europe in central and peripheral monogenic retinal dystrophies.

Authors:  Elena Prokofyeva; Robert Wilke; Gunnar Lotz; Eric Troeger; Torsten Strasser; Eberhart Zrenner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-11       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.